Healthy men test Single-Dose drug in early safety study
NCT ID NCT07166783
First seen Oct 31, 2025 · Last updated May 22, 2026 · Updated 32 times
Summary
This early-phase study looked at how a single 7.5 mg dose of tolvaptan behaves in the body of 10 healthy men aged 18 to 40. The goal was to measure drug levels and check for side effects, not to treat any disease. Results help researchers understand the drug's safety and processing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.